AI assistant
Sending…
PFIZER INC — Director's Dealing 2003
Dec 22, 2003
29831_dirs_2003-12-22_4db5a0e1-3546-41f0-af9d-637afb018ea4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ARQULE INC (ARQL)
CIK: 0001019695
Period of Report: 2003-12-17
Reporting Person: PFIZER INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2003-12-17 | Common Stock | J | 645162 | $4.65 | Acquired | 3273679 | Indirect |
Footnotes
F1: Shares acquired directly from ArQule as an additional equity investment.
F2: Amendment filed to correct the purchase price.
F3: Joint Filer Information
Name: Pfizer Holdings Europe
Address: La Touche House, International Financial Services Centre, Dublin 1, Ireland
Designated Filer: Pfizer Inc.
Issuer and Ticker Symbol: ArQule, Inc. (ARQL)
Date of Event Requiring Statement: December 17, 2003.
Signature: Pfizer Holdings Europe
Signature of Reporting Person: /s/ Brian G. Byala, Director
Date: December 22, 2003
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31